Gain Therapeutics, Inc. (GANX)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Sep 09, 13:20
Gain Therapeutics Market Cap : 77.58M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 79.31M |
| September 04, 2026 | 78.01M |
| September 03, 2026 | 78.88M |
| September 02, 2026 | 77.58M |
| September 01, 2026 | 76.71M |
| August 31, 2026 | 78.01M |
| August 28, 2026 | 76.71M |
| August 27, 2026 | 80.18M |
| August 26, 2026 | 78.45M |
| August 25, 2026 | 82.56M |
| August 24, 2026 | 86.68M |
| August 21, 2026 | 86.90M |
| August 20, 2026 | 85.81M |
| August 19, 2026 | 89.71M |
| August 18, 2026 | 87.98M |
| August 17, 2026 | 88.41M |
| August 14, 2026 | 91.88M |
| August 13, 2026 | 93.83M |
| August 12, 2026 | 91.88M |
| August 11, 2026 | 89.28M |
| August 10, 2026 | 76.71M |
| August 07, 2026 | 78.88M |
| August 06, 2026 | 77.15M |
| August 05, 2026 | 76.48M |
| August 04, 2026 | 74.78M |
| Date | Value |
|---|---|
| August 03, 2026 | 74.36M |
| July 31, 2026 | 71.38M |
| July 30, 2026 | 74.78M |
| July 29, 2026 | 71.81M |
| July 28, 2026 | 73.51M |
| July 27, 2026 | 79.03M |
| July 24, 2026 | 74.36M |
| July 23, 2026 | 77.33M |
| July 22, 2026 | 78.18M |
| July 21, 2026 | 78.18M |
| July 20, 2026 | 69.26M |
| July 17, 2026 | 72.66M |
| July 16, 2026 | 70.53M |
| July 15, 2026 | 71.38M |
| July 14, 2026 | 71.38M |
| July 13, 2026 | 74.78M |
| July 10, 2026 | 76.48M |
| July 09, 2026 | 77.33M |
| July 08, 2026 | 76.05M |
| July 07, 2026 | 76.90M |
| July 06, 2026 | 76.90M |
| July 02, 2026 | 81.15M |
| July 01, 2026 | 84.55M |
| June 30, 2026 | 86.25M |
| June 29, 2026 | 84.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.787B |
| Alnylam Pharmaceuticals, Inc. | 34.14B |
| Anika Therapeutics, Inc. | 278.63M |
| Savara, Inc. | 1.107B |
| Vericel Corp. | 1.991B |
Market Cap Related Metrics
| Price to Book Value | 6.870 |
| Price | 1.79 |
| Earnings Yield | -28.27% |